Patents by Inventor Christopher Rodell

Christopher Rodell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Macrophage Targeted Immunotherapeutics
    Publication number: 20240115514
    Abstract: Disclosed herein are nanoparticles that include one or more cyclodextrin moieties crosslinked by a linker. The cyclodextrin moieties can complex therapeutic (e.g., anticancer) agents, and can be used to treat diseases such as cancer.
    Type: Application
    Filed: June 28, 2023
    Publication date: April 11, 2024
    Inventors: Christopher Rodell, Ralph Weissleder
  • Macrophage Targeted Immunotherapeutics
    Publication number: 20200338011
    Abstract: Disclosed herein are nanoparticles that include one or more cyclodextrin moieties crosslinked by a linker. The cyclodextrin moieties can complex therapeutic (e.g., anticancer) agents, and can be used to treat diseases such as cancer.
    Type: Application
    Filed: October 19, 2018
    Publication date: October 29, 2020
    Inventors: Christopher Rodell, Ralph Weissleder